基于Barnase-Barstar的预定向策略,用于增强的抗瘤疗法 in vivo
G M Proshkina1, E I Shramova1, A B Mirkasyimov2
1Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Academy of Sciences, 16/10 Miklukho-Maklaya Street, Moscow, 117997, Russia.
Biochimie
|September 22, 2024
概括
这项研究引入了一种新的预向策略,用于表皮卵巢癌治疗. 这种创新方法显著增强了细胞毒剂向癌细胞的输送,优于传统方法.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
背景情况:
- 表皮卵巢癌在妇科癌症治疗中提出了重大挑战.
- 新的治疗策略对于改善患者的治疗结果至关重要.
研究的目的:
- 评估一种预定位技术,以增强细胞毒剂对卵巢癌细胞的体内定位.
- 为了比较癌症治疗中预先准与单步主动准的有效性.
主要方法:
- 使用了涉及细菌核糖核酶Barnase及其抗毒素Barstar的预准系统.
- 设计的Barstar融合了架蛋白,以向瘤相关抗原 (HER2,EpCAM) 为主要模块.
- 结合巴纳与纳米脂质体加载Pseudomonas aeruginosa外毒素A (PE40) 作为细胞毒性二级模块.
- 使用共聚焦显微镜和流细胞计验证了模块相互作用.
- 在SKOV-3卵巢癌异种移植的小鼠中评估治疗疗效.
主要成果:
- 在癌细胞表面上证明了Barstar和Barnase模块之间的有效相互作用.
- 预定位方法在减少瘤负担方面显示出明显更大的有效性,而不是单步活跃定位.
- 无论使用的特定准模块,都观察到有效性.
结论:
- 预定位技术提供了一种高度有效的策略,用于增强纳米脂质体封装的细胞毒剂向卵巢癌细胞的输送.
- 这种方法比用于治疗上皮卵巢癌的常规主动向技术有前途.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


